Where Does Dice Therapeutics Inc (DICE) Stock Fall in the Biotechnology Field After It Is Up 1.13% This Week?

Thursday, August 03, 2023 01:23 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Dice Therapeutics Inc (DICE) Stock Fall in the Biotechnology Field After It Is Up 1.13% This Week?

Dice Therapeutics Inc (DICE) is near the top in its industry group according to InvestorsObserver. DICE gets an overall rating of 70. That means it scores higher than 70 percent of stocks. Dice Therapeutics Inc gets a 90 rank in the Biotechnology industry. Biotechnology is number 55 out of 148 industries.

DICE has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on DICE!

See Full DICE Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 70 would rank higher than 70 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Dice Therapeutics Inc Stock Today?

Dice Therapeutics Inc (DICE) stock is trading at $47.48 as of 1:23 PM on Thursday, Aug 3, an increase of $0.09, or 0.2% from the previous closing price of $47.38. Volume today is below average. So far 814,706 shares have traded compared to average volume of 1,853,476 shares. The stock has traded between $47.40 and $47.52 so far today. Click Here to get the full Stock Report for Dice Therapeutics Inc stock.